Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lipid Storage Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableActive Not RecruitingNCT05526664
What this trial is testing

Omics Gaucher Study: Multiomic Approach

Who this might be right for
Gaucher Disease
CENTOGENE GmbH Rostock 25
Post-approval studies (Phase 4)Study completedNCT04656600
What this trial is testing

Study to Evaluate Efficacy and Safety of Imiglucerase Treatment in Chinese Patients With Gaucher Disease Type Ⅲ

Who this might be right for
Gaucher's Disease
Sanofi 12
Post-approval studies (Phase 4)Study completedNCT06019728
What this trial is testing

A Prospective Study to Investigate Safety and Tolerability of Shorter Infusion of Fabrazyme

Who this might be right for
Fabry's Disease
Sanofi 8
Testing effectiveness (Phase 2)Study completedNCT02004704
What this trial is testing

A Long-Term Study of Olipudase Alfa in Patients With Acid Sphingomyelinase Deficiency

Who this might be right for
Sphingomyelin Lipidosis
Genzyme, a Sanofi Company 25
Not applicableEnded earlyNCT07455864
What this trial is testing

Lysosomal Acid Lipase Deficiency in Risk Groups

Who this might be right for
Lysosomal Acid Lipase Deficiency
AstraZeneca 25
Large-scale testing (Phase 3)WithdrawnNCT05815004
What this trial is testing

An Efficacy and Safety Study of AVR-RD-02 Compared to Enzyme Replacement Therapy for Treatment of Gaucher Disease Type 3

Who this might be right for
Gaucher Disease, Type 3
AVROBIO
Not applicableLooking for participantsNCT05698901
What this trial is testing

Biomarkers and Cardiac Imaging Diagnostic Assay for Monitoring Patients With Fabry Disease

Who this might be right for
Fabry Disease
Mackay Memorial Hospital 150
Not applicableStudy completedNCT01626092
What this trial is testing

Reduced-Intensity Hematopoietic Stem Cell Transplant for High Risk Lysosomal and Peroxisomal Disorders

Who this might be right for
Lysosomal Storage DiseasePeroxisomal Disorder
Masonic Cancer Center, University of Minnesota 3
Not applicableStudy completedNCT05109793
What this trial is testing

GM1 and GM2 Gangliosidosis PROspective Neurological Disease TrajectOry Study (PRONTO)

Who this might be right for
GM1 GangliosidosisSandhoff DiseaseTay-Sachs Disease
Azafaros B.V. 31
Not applicableUnknownNCT05816993
What this trial is testing

Assessment of Neurological Manifestations in Gaucher Disease Patients

Who this might be right for
Gaucher Disease
Assiut University 45
Testing effectiveness (Phase 2)Study completedNCT00730314
What this trial is testing

Unrelated Hematopoietic Stem Cell Transplantation(HSCT) for Genetic Diseases of Blood Cells

Who this might be right for
Sickle Cell DiseaseThalassemiaAnemia+9 more
Children's Hospital Los Angeles 25
Not applicableStudy completedNCT06801288
What this trial is testing

Diagnostic Role of Renal Biopsy in Patients With Fabry Disease

Who this might be right for
Fabry Disease
IRCCS Azienda Ospedaliero-Universitaria di Bologna 80
Large-scale testing (Phase 3)Looking for participantsNCT06904261
What this trial is testing

Migalastat in Pediatric Subjects (2 to <12 Yrs) With Fabry Disease and Amenable GLA Variants

Who this might be right for
Fabry Disease
Amicus Therapeutics 8
Testing effectiveness (Phase 2)Study completedNCT02107846
What this trial is testing

An Open-Label, Dose Escalation Study to Evaluate the Safety and the Pharmacokinetics of Oral PRX-112

Who this might be right for
Gaucher Disease
Protalix 10
Not applicableStudy completedNCT04845958
What this trial is testing

A Non-Interventional National Study in Pediatric Patients With Unexplained Enlarged Spleen

Who this might be right for
Gaucher Disease, SplenomegalyAcid SphingoMyelinase Deficiency
Sanofi 60
Testing effectiveness (Phase 2)Study completedNCT01560182
What this trial is testing

Gene Therapy for Metachromatic Leukodystrophy (MLD)

Who this might be right for
Lysosomal Storage DiseaseMetachromatic Leukodystrophy
Orchard Therapeutics 20
Not applicableLooking for participantsNCT05473637
What this trial is testing

Taiwan Associated Genetic and Nongenetic Small Vessel Disease

Who this might be right for
Cerebral Small Vessel DiseasesCadasilHTRA1-Related Autosomal Dominant Cerebral Angiopathy+5 more
National Taiwan University Hospital 500
Not applicableNot Yet RecruitingNCT03725670
What this trial is testing

Direct Lentiviral Injection Gene Therapy for MLD

Who this might be right for
Metachromatic Leukodystrophy (MLD)
Shenzhen Geno-Immune Medical Institute 10
Not applicableStudy completedNCT04050137
What this trial is testing

Therapeutic Exercise to Treat Neuropathic Pain

Who this might be right for
Gaucher DiseaseFabry Disease
Universidad de Zaragoza 5
Testing effectiveness (Phase 2)Study completedNCT01488097
What this trial is testing

Extension Study to Evaluate the Long-Term Safety, Tolerability, and Efficacy of SBC-102 (Sebelipase Alfa) in Adult Subjects With Lysosomal Acid Lipase Deficiency

Who this might be right for
Cholesterol Ester Storage Disease (CESD)Lysosomal Acid Lipase DeficiencyLAL-Deficiency
Alexion Pharmaceuticals, Inc. 8
Next Page